Search
for
Sort by
Research 361–390 of 525
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Coexistence of dermatomyositis and alopecia areata: Insight into pathogenesis
- Clinical Effectiveness of Two Old Immunosuppressant Drugs, Methotrexate and Azathioprine, in the Treatment of Lichen Planopilaris: A Randomized Clinical Trial
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Manifestation of pityriasis amiantacea following initiation of minoxidil
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- Squaric Acid Dibutylester Promotes Innate Immune-Driven Hair Growth with CD206+ Macrophage Accumulation in the Dermis
- Bacteroides fragilis and Microbacterium as Microbial Signatures in Hashimoto’s Thyroiditis
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- JAK inhibitors in dermatology: The promise of a new drug class
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Impact of Vitamin D on Immunopathology of Hashimoto’s Thyroiditis: From Theory to Practice
- Cephalalgic Alopecia Areata
- Immunology of alopecia areata
- Genetic Polymorphisms of Immunity Regulatory Genes and Alopecia Areata Susceptibility in Jordanian Patients
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Targeted immunotherapy for hair regrowth and regeneration
- Immunology of the Human Nail Apparatus: The Nail Matrix Is a Site of Relative Immune Privilege
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study